Mereo BioPharma Group

2.44
-0.01 (-0.41%)
At close: Feb 28, 2025, 3:59 PM
2.37
-3.07%
After-hours: Feb 28, 2025, 07:53 PM EST

Mereo BioPharma Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 10M 1.51M 36.46M 393K -122K n/a -3.29M n/a
Cost of Revenue 2.57M 936K 17.91M 16.35M 23.61M 22.7M 34.61M 24.56M
Gross Profit 7.43M 571K 18.56M -15.95M -23.73M -22.7M -37.89M -24.56M
Operating Income -28.42M -43.57M -20.94M -37.57M -39.52M -35.21M -45.3M -36.18M
Interest Income 2.13M 696K 1K 44K 377K 306.83K 826.86K 195.14K
Pretax Income -30M -36.09M 14.24M -166.45M -41.12M -37.31M -46.95M -33.72M
Net Income -29.47M -34.2M 12.72M -163.63M -34.84M -32.03M -38.8M -28.39M
Selling & General & Admin 18.42M 19.54M 15.93M 21.22M 15.91M 12.5M 10.7M 11.62M
Research & Development 17.42M 24.96M 23.56M -16.35M -23.61M 22.7M 34.61M 24.56M
Other Expenses n/a 811K n/a n/a n/a n/a -293.33K n/a
Operating Expenses 35.84M 44.51M 39.49M 21.22M 15.91M 12.5M 10.7M 11.62M
Interest Expense 2.88M 3.36M 4M 6.38M 3.5M 2.36M 1.09M 179.76K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 38.42M 43.57M 57.4M 37.57M 39.52M 35.21M 45.3M 36.18M
Income Tax -532K -1.9M 1.52M -2.82M -6.27M -5.28M -8.15M -5.33M
Shares Outstanding (Basic) 659.45M 603.2M 583.67M 338.95M 89.34M 71.14M 69.01M 44.79M
Shares Outstanding (Diluted) 659.45M 603.2M 583.67M 338.95M 89.42M 71.14M 69.01M 44.79M
EPS (Basic) -220.04 -350.07 149.93 -3.3K -2.58K -2.87K -3.8K -3.91K
EPS (Diluted) -220.04 -350.07 149.93 -3.3K -2.58K -2.87K -3.8K -3.91K
EBITDA -26.06M -42.06M -5M -37.52M -37.56M -34.86M -44.44M -38.41M
Depreciation & Amortization 1.06M 1.51M 866.47K 44K 1.95M 37.8K 36.08K 32.94K